PATH-30. BIOLOGIC AND CLINICAL SIGNIFICANCE OF NEOPLASTIC AND IMMUNE CELL STATES IN GROUP3 AND GROUP 4 MEDULLOBLASTOMA

MLA

Saleembhasha Asanigari, et al. “Path-30. Biologic and Clinical Significance of Neoplastic and Immune Cell States in Group3 and Group 4 Medulloblastoma.” Neuro-Oncology, vol. 24, Nov. 2022, pp. vii156-vii157. EBSCOhost, https://doi.org/10.1093/neuonc/noac209.603.

APA

Saleembhasha Asanigari, Bharati Mehani, Di Wu, Hye-Jung Chung, & Kenneth Aldape. (2022). Path-30. Biologic and Clinical Significance of Neoplastic and Immune Cell States in Group3 and Group 4 Medulloblastoma. Neuro-Oncology, 24, vii156-vii157. https://doi.org/10.1093/neuonc/noac209.603

Chicago

Saleembhasha Asanigari, Bharati Mehani, Di Wu, Hye-Jung Chung, and Kenneth Aldape. 2022. “Path-30. Biologic and Clinical Significance of Neoplastic and Immune Cell States in Group3 and Group 4 Medulloblastoma.” Neuro-Oncology 24 (November): vii156-vii157. doi:10.1093/neuonc/noac209.603.